Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Celgene
Celgene
Bristol Myers flunks frontline multiple myeloma trial, turning attention to cell therapy
Endpoints
Mon, 03/9/20 - 10:52 am
Bristol-Myers Squibb
Celgene
M&A
clinical trials
Multiple Myeloma
Empliciti
AbbVie
Revlimid
Bristol Myers Squibb unveils new branding, will phase out Celgene brand
Medical Marketing and Media
Thu, 03/5/20 - 10:27 am
Bristol-Myers Squibb
Celgene
rebranding
M&A
A Big Month Ahead for the FDA and Bristol-Myers Squibb
Motley Fool
Sat, 02/22/20 - 11:39 pm
Bristol-Myers Squibb
Celgene
FDA
ozanimod
Opdivo
Reblozyl
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates
Motley Fool
Thu, 02/6/20 - 11:47 am
Bristol-Myers Squibb
earnings
Celgene
M&A
Celgene taps Bristol-Myers salesforce to bolster key blood cancer launches
Fierce Pharma
Wed, 01/15/20 - 11:13 pm
Celgene
Bristol-Myers Squibb
blood cancer
JPM: Bristol chief says one-third of Celgene cost cuts will hit in 2020
Fierce Pharma
Mon, 01/13/20 - 11:43 pm
M&A
JPMHC 2020
Bristol-Myers Squibb
Celgene
Giovanni Caforio
Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive
Reuters
Sat, 01/11/20 - 12:06 am
Bristol-Myers Squibb
Celgene
M&A
liso-cel
ozanimod
bb2121
FDA
Bristol-Myers unloads old-school plant as it readies for CAR-T future
Fierce Pharma
Tue, 01/7/20 - 10:47 pm
Bristol-Myers Squibb
Celgene
CAR-T
M&A
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto
Xconomy
Tue, 01/7/20 - 10:53 am
Amira Pharmaceuticals
Bristol-Myers Squibb
Celgene
PharmAkea
Galecto Biotech
fibrotic disease
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition
Motley Fool
Sun, 12/22/19 - 12:32 am
Bristol-Myers Squibb
Celgene
M&A
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
M&A
Sanofi
Merck
AbbVie
Allergan
Bristol-Myers Squibb
Celgene
FTC
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Motley Fool
Mon, 12/16/19 - 10:41 am
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
After Its Celgene Acquisition, Bristol-Myers Squibb's Future Looks Bright
Motley Fool
Thu, 12/12/19 - 05:25 pm
Celgene
M&A
Bristol-Myers Squibb
Deal of the Year: Bristol-Myers Squibb buys Celgene
Biopharma Dive
Mon, 12/9/19 - 09:51 am
M&A
Bristol-Myers Squibb
Celgene
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable
Motley Fool
Thu, 12/5/19 - 11:32 pm
Celgene
Editas Medicine
Juno Therapeutics
CRISPR
gene editing
BMS investors bet big on 3 newly acquired Celgene drugs for cancer and MS
Fierce Pharma
Sun, 11/24/19 - 11:35 pm
Bristol-Myers Squibb
Celgene
M&A
ozanimod
liso-cel
bb2121
Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
Stat
Fri, 11/22/19 - 10:00 am
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
Merck
M&A
Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla
Fierce Pharma
Thu, 11/21/19 - 06:29 pm
Amgen
Otezla
Celgene
psoriasis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »